Literature DB >> 12198771

Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.

Brunhilde Felding-Habermann1, Emilia Fransvea, Timothy E O'Toole, Lisa Manzuk, Barbara Faha, Mary Hensler.   

Abstract

Early metastasis is the primary cause of death in melanoma patients. The adhesion receptor integrin alpha v beta 3 contributes to tumor cell functions that are potentially involved in melanoma growth and metastasis. We tested whether integrin alpha v beta 3 supports metastasis of human melanoma cells when injected into the bloodstream of immune deficient mice. Comparing variants of the same melanoma cell type that expressed either alpha v beta 3, alpha IIb beta 3 or no beta 3 integrin, we found that only alpha v beta 3 strongly supported metastasis. Inhibition of tumor cell alpha v beta 3 function reduced melanoma metastasis significantly and prolonged animal survival. To understand mechanisms that allow alpha v beta 3, but not alpha IIb beta 3 to support melanoma metastasis, we analyzed proteolytic and migratory activities of the melanoma cell variants. Melanoma cells expressing alpha v beta 3, but not those expressing alpha IIb beta 3 or no beta 3 integrin, produced the active form of metalloproteinase MMP-2 and expressed elevated mRNA levels of MT1-MMP and TIMP-2. This indicates an association between alpha v beta 3 expression and protease processing. Furthermore, alpha v beta 3 expression was required for efficient melanoma cell migration toward the matrix proteins fibronectin and vitronectin. The results suggest that expression of integrin alpha v beta 3 promotes the metastatic phenotype in human melanoma by supporting specific adhesive, invasive and migratory properties of the tumor cells and that the related integrin alpha IIb beta 3 cannot substitute for alpha v beta 3 in this respect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198771     DOI: 10.1023/a:1016377114119

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  42 in total

1.  Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression.

Authors:  U B Hofmann; J R Westphal; E T Waas; J C Becker; D J Ruiter; G N van Muijen
Journal:  J Invest Dermatol       Date:  2000-10       Impact factor: 8.551

Review 2.  Matrix metalloproteinases in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

3.  Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow.

Authors:  B Felding-Habermann; R Habermann; E Saldívar; Z M Ruggeri
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

4.  Thrombin-thrombomodulin activation of protein C facilitates the activation of progelatinase A.

Authors:  S R Pekovich; P E Bock; R L Hoover
Journal:  FEBS Lett       Date:  2001-04-06       Impact factor: 4.124

5.  Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.

Authors:  E I Deryugina; M A Bourdon; K Jungwirth; J W Smith; A Y Strongin
Journal:  Int J Cancer       Date:  2000-04-01       Impact factor: 7.396

Review 6.  The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis.

Authors:  W G Stetler-Stevenson
Journal:  Surg Oncol Clin N Am       Date:  2001-04       Impact factor: 3.495

7.  Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.

Authors:  U B Hofmann; J R Westphal; A A Van Kraats; D J Ruiter; G N Van Muijen
Journal:  Int J Cancer       Date:  2000-07-01       Impact factor: 7.396

8.  The role of carboxy-terminal glycosaminoglycan-binding domain of vitronectin in cytoskeletal organization and migration of endothelial cells.

Authors:  P Thiagarajan; A Le; M B Snuggs; B VanWinkle
Journal:  Cell Adhes Commun       Date:  1996-11

9.  Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.

Authors:  B Felding-Habermann; B M Mueller; C A Romerdahl; D A Cheresh
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

10.  Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method.

Authors:  H Wong; W D Anderson; T Cheng; K T Riabowol
Journal:  Anal Biochem       Date:  1994-12       Impact factor: 3.365

View more
  53 in total

1.  Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumours.

Authors:  Johanne Seguin; Céline Nicolazzi; Nathalie Mignet; Daniel Scherman; Guy G Chabot
Journal:  Tumour Biol       Date:  2012-06-07

2.  Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk.

Authors:  Anna Jakubowska; Jacek Gronwald; Janusz Menkiszak; Bohdan Górski; Tomasz Huzarski; Tomasz Byrski; Lutz Edler; Jan Lubinski; Rodney J Scott; Ute Hamann
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

3.  Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation.

Authors:  DeannaLee M Beauvais; Alan C Rapraeger
Journal:  J Cell Sci       Date:  2010-11-01       Impact factor: 5.285

4.  Matrix metalloproteinase 2-integrin alpha(v)beta3 binding is required for mesenchymal cell invasive activity but not epithelial locomotion: a computational time-lapse study.

Authors:  Paul A Rupp; Richard P Visconti; András Czirók; David A Cheresh; Charles D Little
Journal:  Mol Biol Cell       Date:  2008-10-15       Impact factor: 4.138

5.  αvβ3 Integrin Mediates Radioresistance of Prostate Cancer Cells through Regulation of Survivin.

Authors:  Tao Wang; Jiayi Huang; Mai Vue; Michael R Alavian; Hira Lal Goel; Dario C Altieri; Lucia R Languino; Thomas J FitzGerald
Journal:  Mol Cancer Res       Date:  2018-09-28       Impact factor: 5.852

6.  Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.

Authors:  Ya-Min Fu; Zu-Xi Yu; Huimin Lin; Xing Fu; Gary G Meadows
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

Review 7.  Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner.

Authors:  Thomas Dittmar; Christoph Heyder; Eva Gloria-Maercker; Wolfgang Hatzmann; Kurt S Zänker
Journal:  Clin Exp Metastasis       Date:  2007-09-08       Impact factor: 5.150

8.  Insulin-like growth factor (IGF) signaling requires αvβ3-IGF1-IGF type 1 receptor (IGF1R) ternary complex formation in anchorage independence, and the complex formation does not require IGF1R and Src activation.

Authors:  Masaaki Fujita; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2012-12-14       Impact factor: 5.157

9.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10

10.  External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas.

Authors:  Karolina Partheen; Kristina Levan; Lovisa Osterberg; Ingela Claesson; Karin Sundfeldt; György Horvath
Journal:  BMC Cancer       Date:  2009-09-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.